All In Biotech

Drug Trial Radar · NCT04483115

Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension

Multi-center, Randomized,Placebo and Positive Controlled Clinical Study of TPN171H Tablets on Acute Haemodynamics in Patients with Pulmonary Arterial Hypertension

Last checked: Nov 20, 2026Latest source record: Dec 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Nov 16, 2020

Primary completion

Jun 29, 2022

Study completion Jun 29, 2022

Sponsor

Lead sponsor
Vigonvita Life SciencesIndustry
Sponsor type
Industry
Collaborators
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
First posted
Jul 23, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a phase IIa proof-of-concept study to evaluate the effect of single-dose TPN171H tablets on acute haemodynamic parameters in patients with pulmonary arterial hypertension.The trial is expected to include 60 patients, divided into 6 groups, according to 1:1:1:1:1:1 into the placebo group and the test drugs 2.5mg, 5mg, 10mg group, tadalafil tablets 20mg, 40mg group, each group 10 cases.

Conditions

  • Pulmonary Arterial Hypertension

Interventions

  • TPN171HDrug

    Tablets; Oral; Single dose

  • PlaceboDrug

    Tablets; Oral; Single dose

  • TadalafilDrug

    Tablets; Oral; Single dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of the maximum change in pulmonary vascular resistance(PVR) to the second baselineTime frame: Within 24 hours after drug administration

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China

  • Peking University First Hospital

    Beijing, Beijing Municipality, China

  • Fuwai Hospital CAMS&PUMC

    Beijing, Beijing Municipality, China

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • Gansu Provincial Hospital

    Lanzhou, Gansu, China

  • Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology

    Wuhan, Hubei, China

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • First Affiliated Hospital Of Gannan Medical University

    Ganzhou, Jiangxi, China

  • Shanghai Pulmonary Hospital

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.